Поиск
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.

Список литературы

  1. Maurer M. и др. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update // Allergy. 2018. Т. 73, № 8. С. 1575–1596.
  2. Caballero T. и др. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations. // J. Investig. Allergol. Clin. Immunol. 2011. Т. 21, № 6. С. 422–441.
  3. Cicardi M. и др. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group // Allergy. 2014. Т. 69, № 5. С. 602–616.
  4. Obtułowicz K. Bradykinin-mediated angioedema // Polish Arch. Intern. Med. 2016. Т. 126, № 1–2. С. 76–85.
  5. Picard C. и др. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015 // J. Clin. Immunol. 2015. Т. 35, № 8. С. 696–726.
  6. Germenis A.E., Speletas M. The Genetics of Hereditary Angioedema the Iceberg Slowly Emerges // J. Angioedema. 2016. Т. 2, № 1. С. 8–17.
  7. Germenis A.E., Speletas M. Genetics of Hereditary Angioedema Revisited // Clin. Rev. Allergy Immunol. Clinical Reviews in Allergy & Immunology, 2016. Т. 51, № 2. С. 170–182.
  8. Santacroce R. и др. The Genetics of Hereditary Angioedema: A Review // J. Clin. Med. 2021. Т. 10, № 9. С. 2023.
  9. Davis A., Lu F., Mejia P. C1 inhibitor, a multi-functional serine protease inhibitor // Thromb. Haemost. 2010. Т. 104, № 11. С. 886–893.
  10. Bork K. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema // Immunotherapy. 2014. Т. 6, № 5. С. 533–551.
  11. Kaplan A.P., Joseph K. Pathogenesis of Hereditary Angioedema: The Role of the Bradykinin- Forming Cascade // Immunol. Allergy Clin. North Am. Elsevier Inc, 2017. Т. 37, № 3. С. 513–525.
  12. Caccia S., Suffritti C., Cicardi M. Pathophysiology of Hereditary Angioedema // Pediatr. Allergy. Immunol. Pulmonol. 2014. Т. 27, № 4. С. 159–163.
  13. Bas M. и др. Nonallergic angioedema: role of bradykinin. // Allergy. 2007. Т. 62, № 8. С. 842– 856.
  14. Levi M., Cohn D.M., Zeerleder S. Hereditary angioedema: Linking complement regulation to the coagulation system // Res. Pract. Thromb. Haemost. 2019. Т. 3, № 1. С. 38–43.
  15. van Geffen M. и др. Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency // Clin. Exp. Immunol. 2012. Т. 167, № 3. С. 472–478.
  16. Cicardi M. и др. Novelties in the diagnosis and treatment of angioedema // J. Investig. Allergol. Clin. Immunol. 2016. Т. 26, № 4. С. 212–221.
  17. Bafunno V. и др. Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema // J. Allergy Clin. Immunol. 2018. Т. 141, № 3. С. 1009–1017.
  18. Bork K. и др. Hereditary angioedema with a mutation in the plasminogen gene // Allergy. 2018. Т. 73, № 2. С. 442–450.

  1. Veronez C.L. и др. Genetic Variation of Kallikrein-Kinin System and Related Genes in Patients With Hereditary Angioedema // Front. Med. 2019. Т. 6, № February. С. 1–6.
  2. Bork K. и др. Guideline: Hereditary angioedema due to C1 inhibitor deficiency: S1 Guideline of the German Society for Angioedema (Deutsche Gesellschaft für Angioödeme, DGA), German Society for Internal Medicine (Deutsche Gesellschaft für Innere Medizin, DGIM), German S // Allergo J. Int. 2019. Т. 28, № 1. С. 16–29.
  3. Alonso M.L.O. и др. Hereditary angioedema: a prospective study of a Brazilian single‐center cohort // Int. J. Dermatol. 2019. С. ijd.14676.
  4. Deroux A. и др. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema // Clin. Exp. Immunol. 2016. Т. 185, № 3. С. 332–337.
  5. F12-related hereditary angioedema with normal C1Inh.
  6. Zuraw B.L. Hereditary angioedema with normal C1 inhibitor: Four types and counting // J. Allergy Clin. Immunol. 2018. Т. 141, № 3. С. 884–885.
  7. Marcelino-Rodriguez I. и др. Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics // Front. Genet. 2019. Т. 10.
  8. Steiner U.C. и др. Hereditary angioedema due to C1 - inhibitor deficiency in Switzerland: clinical characteristics and therapeutic modalities within a cohort study // Orphanet J. Rare Dis. 2016. Т. 11, № 1. С. 43.
  9. Bouillet L. и др. Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients // Ann. Allergy, Asthma Immunol. American College of Allergy, Asthma & Immunology, 2013. Т. 111, № 4. С. 290–294.
  10. Bork K. и др. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. // Am. J. Med. 2006. Т. 119, № 3. С. 267–274.
  11. Bork K., Hardt J., Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency // J. Allergy Clin. Immunol. 2012. Т. 130, № 3. С. 692–697.
  12. Xu Y.-Y. и др. Upper airway edema in 43 patients with hereditary angioedema // Ann. Allergy, Asthma Immunol. 2014. Т. 112, № 6. С. 539-544.e1.
  13. Martinez-Saguer I., Farkas H. Erythema Marginatum as an Early Symptom of Hereditary Angioedema: Case Report of 2 Newborns // Pediatrics. 2016. Т. 137, № 2. С. e20152411.
  14. Zotter Z. и др. The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency. // Orphanet J. Rare Dis. 2014. Т. 9, № 44. С. 1–6.
  15. Hahn J. и др. Angioedema // Dtsch. Aerzteblatt Online. 2017. Т. 114, № 29–30. С. 489–496.
  16. Weldon D. Differential Diagnosis of Angioedema // Immunol. Allergy Clin. North Am. 2006. Т. 26, № 4. С. 603–613.
  17. Farkas H. Management of upper airway edema caused by hereditary angioedema // Allergy, Asthma Clin. Immunol. 2010. Т. 6, № 19. С. 1–8.
  18. Misra L., Khurmi N., Trentman T. Angioedema: Classification, management and emerging therapies for the perioperative physician // Indian J. Anaesth. 2016. Т. 60, № 8. С. 534–541.
  19. Giavina-Bianchi P. и др. Brazilian Guidelines for Hereditary Angioedema Management - 2017 Update Part 1: Definition, Classification and Diagnosis // Clinics. 2018. Т. 73.

  1. Gobert D. и др. Angiœdèmes par déficit acquis en C1-inhibiteur : recommandations du CREAK pour le diagnostic et la prise en charge // La Rev. Médecine Interne. 2020. Т. 41, № 12. С. 838– 842.
  2. Bowen T. и др. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema // Allergy, Asthma Clin. Immunol. 2010. Т. 6, № 24. С. 1–13.
  3. Caballero T. и др. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. // J. Investig. Allergol. Clin. Immunol. 2011. Т. 21, № 5. С. 333–347.
  4. Agostoni A. и др. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond // J. Allergy Clin. Immunol. 2004. Т. 114, № 3. С. S51–S131.
  5. Martinez-Saguer I. и др. Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study // Transfusion. 2014. Т. 54, № 6. С. 1552–1561.
  6. Richards S. и др. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology // Genet. Med. 2015. Т. 17, № 5. С. 405–423.
  7. Farkas H. и др. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency // Allergy Eur. J. Allergy Clin. Immunol. 2017. Т. 72, № 2. С. 300–313.
  8. Aabom A. и др. Clinical characteristics and real-life diagnostic approaches in all Danish children with hereditary angioedema // Orphanet J. Rare Dis. 2017. Т. 12, № 1. С. 55.
  9. Craig T. и др. WAO Guideline for the Management of Hereditary Angioedema // World Allergy Organ. J. 2012. Т. 5, № 12. С. 182–199.
  10. Tarzi M.D. и др. An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema // Clin. Exp. Immunol. 2007. Т. 149, № 3. С. 513–516.
  11. Pedrosa M. и др. Complement Study Versus CINH Gene Testing for the Diagnosis of Type I Hereditary Angioedema in Children // J. Clin. Immunol. 2016. Т. 36, № 1. С. 16–18.
  12. Karim Y. Normal complement C4 values do not exclude hereditary angioedema // J. Clin. Pathol. 2004. Т. 57, № 2. С. 213–214.
  13. Nielsen E. и др. Activation of the Complement, Coagulation, Fibrinolytic and Kallikrein-Kinin Systems During Attacks of Hereditary Angioedema // Scand. J. Immunol. 1996. Т. 44, № 2. С. 185–192.
  14. Zanichelli A. и др. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency // J. Allergy Clin. Immunol. Pract. 2017. Т. 5, № 5. С. 1307–1313.
  15. Riedl M.A. и др. Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data // J. Allergy Clin. Immunol. Pract. Elsevier, 2016. Т. 4, № 5. С. 963–971.
  16. O’Shaughnessy D.F. и др. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant // Br. J. Haematol. 2004. Т. 126, № 1. С. 11–28.
  17. Moreno A.S. и др. Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor // Int. Arch. Allergy Immunol. 2015. Т. 166, № 2. С. 114– 120.

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*